所有图片(4)
About This Item
线性分子式:
CH3(CH2)8CH2SO3Na
CAS号:
分子量:
244.33
Beilstein:
3918920
EC號碼:
MDL號碼:
分類程式碼代碼:
12161900
PubChem物質ID:
NACRES:
NA.25
推荐产品
描述
anionic
品質等級
化驗
~98%
形狀
powder
分子量
244.33 g/mol
技術
LC/MS: suitable
mp
>300 °C (lit.)
SMILES 字串
[Na+].CCCCCCCCCCS([O-])(=O)=O
InChI
1S/C10H22O3S.Na/c1-2-3-4-5-6-7-8-9-10-14(11,12)13;/h2-10H2,1H3,(H,11,12,13);/q;+1/p-1
InChI 密鑰
AIMUHNZKNFEZSN-UHFFFAOYSA-M
正在寻找类似产品? 访问 产品对比指南
一般說明
1-癸磺酸钠是一种阴离子表面活性剂，用于通过 HPLC 和离子对液相色谱分析有机小分子化合物。阴离子磺酸盐抗衡离子允许正电荷分析物的分离和分辨。使用毛细管电泳评估 1-癸磺酸钠的临界胶束浓度（CMC）。一些研究报道了羟丙基甲基纤维素和几种离子表面活性剂（如 1-癸磺酸钠）之间的相互作用。
應用
在研究中使用1-癸烷磺酸钠来评估 zn2+离子电还原的机理。它还被用于研究胍化合物在多孔石墨碳上的保留机制。
HPLC（包括肽和蛋白质）分析的离子缔合试剂。
特點和優勢
- 适用于高效液相色谱（HPLC）和离子对液相色谱
- 允许分离带正电的分析物。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
Influence of sodium 1-decanesulfonate on the enthalpy of activation of two-step Zn2+ ions electroreduction
Nieszporek
Journal of Electroanalytical Chemistry (Lausanne Switzerland), 662, 8-8 (2011)
Y Inamoto et al.
Journal of chromatography. B, Biomedical sciences and applications, 707(1-2), 111-120 (1998-06-05)
The retention mechanism of guanidino compounds on a porous graphitic carbon seemed to be mainly hydrophobic interaction, according to the retention factors in buffer solutions and the results of an analysis by computational chemical calculation using molecular mechanics (MM2). The
J J Berzas Nevado et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 769(2), 261-268 (2002-05-09)
A micellar electrokinetic capillary chromatography (MEKC) for determining fluoxetine and its metabolite (norfluoxetine) is proposed. Optimal conditions for the quantitative separation were investigated. A background electrolyte solution consisting of 5 mM phosphate buffer adjusted to pH 12.3 and 40 mM
Miriam Gochin et al.
Journal of medicinal chemistry, 52(14), 4338-4344 (2009-06-19)
The hydrophobic pocket within the coiled coil domain of HIV-1 gp41 is considered to be a hot-spot suitable for small molecule intervention of fusion, although so far it has yielded only microM inhibitors. Previous peptide studies have identified specific hydrophobic
Luigi Battaglia et al.
Journal of pharmaceutical sciences, 103(7), 2157-2165 (2014-05-16)
The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experimental work, solid lipid nanoparticles (SLN), prepared according to fatty acid coacervation
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门